Digital health innovation continues moving full-force in transforming the business of healthcare. For pharma and medtech companies in particular, this ongoing shift has pushed them to identify ways to create value for patients beyond the drugs themselves. From new partnerships between digital health and life science companies to revamped commercial models, collecting and extracting insights from data is at the core of these growth opportunities. But navigating the rapidly evolving terrain is no simple task. We chatted with ZS Associates Principal Pete Masloski to discuss how he works with clients to help identify, develop, and commercialize digital health solutions—and where he sees patients benefiting as a result.
In a banner year for digital health funding, AI/ML companies raced to the top in dollars raised, investors showed excitement about on-demand healthcare services, and more women CEOs closed rounds than ever before—though they still represent a small sliver of the pie.
To get to the heart of what the current funding environment means for the future of the sector, we spoke with Sitka’s Kelsey Mellard and Flare Capital’s Michael Greeley about how entrepreneurs should approach fundraising in a capital-rich market, whether valuations are too high, what milestones investors look for before signing the check, and why digital health is primed for more acquisitions.
With a record $8.1B in funding and the absence of an equally robust exit market, there is more scrutiny on digital health than ever before. Will value creation track with recent investment trends? To provide some structure around this question, we validated a simple framework with fellow investors to assess the current “bubbliness” of digital health. Our verdict: digital health is not in a bubble.
Since 2015, Blue Shield of California has partnered with Rock Health to gain exposure to digital health and elevate its position as an innovative healthcare company. Through its partnership with Rock Health, Blue Shield of California has showcased thought leadership, collaborated on research, and gained unparalleled insight into the frontlines of healthcare innovation.
Each year, Rock Health, Fenwick & West, Goldman Sachs, and Square 1 Bank honor those making exceptional progress in driving resources, attention, and innovation toward a massively better healthcare system. From a commitment to hiring diverse talent to writing policy that incentivizes innovation to investing in new ideas, we want to recognize the people and organizations making digital health thrive. Today, we’re excited to announce the winners of the Top 50 in Digital Health 2019.
In just over a month, countless healthcare leaders, deal makers, investors, and startups will flock to San Francisco for the 37th annual JP Morgan Healthcare Conference. It’s where big deals get done (and big bucks are shelled out for meeting space in hotel bars)—but there’s plenty of room for fun, too. Here’s our list of can’t-miss healthcare events for digital health nerds at JPM 2019.
At the close of its third quarter, 2018 is already the most-funded year ever for digital health startups. There has never been a better time to raise money, with founders securing larger and more frequent rounds. Yet numbers alone don’t tell the full story of the progress made in digital health thus far in 2018.
Health systems often have to decide whether to invest in building new products and services or to look outside to partner. At Sutter Health, the Design & Innovation team does both. Located in the epicenter of Silicon Valley, it partners with cutting-edge organizations to fast-track, test, and scale solutions that enhance its internal human-centered design & build capabilities.
Ali Diab has spent the past five years building Rock Health portfolio company Collective Health—a cloud-based, integrated health benefits platform that enables self-insured employers to get more out of their healthcare investment while taking better care of their people. With Ali at the helm, Collective has not only helped employers and their people dramatically drive healthcare costs down—it’s also kept the value of diversity at the forefront, closing the gender wage gap along the way.
Women are critical stakeholders in healthcare, serving as workers, caregivers, and consumers—yet they do not have an equal voice in the ranks of leadership. Our goal with this annual report is to contribute to a meaningful and actionable dialogue around women in leadership, with the hopes of providing a foundation for our industry to finally turn this dialogue into action.
After seven years, we’ve seen $23B invested into thousands of digital health companies. But we wanted to know: what has been the real-world impact of digital health? We were moved to learn just how many lives had been significantly changed by a new wave of technology. We aim to shift the digital health dialogue from one focused on the degree of investment and future expectations to one about digital health’s effect on patients and healthcare outcomes. In that spirit, this ongoing project brings you stories of people living far outside Silicon Valley and the companies shifting the healthcare status quo who have made an impact on their lives.
AI in healthcare feels inevitable: Optimists predict that artificial intelligence and machine learning (AI/ML) will diagnose disease better and earlier, treat illness more precisely, and engage patients more efficiently than today’s healthcare system does. On top of this, AI/ML is expected to streamline business operations and restore sanity (and humanity) to the clinician experience. To separate hype from reality, read our 50-page white paper, Demystifying AI and Machine Learning in Healthcare.